What is the impact of blood pressure on neurological symptoms and the risk of ESKD in primary and secondary thrombotic microangiopathies based on clinical presentation: a retrospective study

[1]  S. Sadallah,et al.  Malignant hypertension and thrombotic microangiopathy: complement as a usual suspect. , 2020, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  E. Mishima,et al.  Concurrent analogous organ damage in the brain, eyes, and kidneys in malignant hypertension: reversible encephalopathy, serous retinal detachment, and proteinuria , 2020, Hypertension Research.

[3]  A. Sved,et al.  Sympathetic Nervous System Contributions to Hypertension: Updates and Therapeutic Relevance. , 2020, The Canadian journal of cardiology.

[4]  F. Petitprez,et al.  Impact of hypertensive emergency and rare complement variants on the presentation and outcome of atypical hemolytic uremic syndrome , 2019, Haematologica.

[5]  C. Vigneau,et al.  Etiology and Outcomes of Thrombotic Microangiopathies. , 2019, Clinical journal of the American Society of Nephrology : CJASN.

[6]  Publisher's Note , 2018, Anaesthesia.

[7]  D. Salant,et al.  Thrombotic Microangiopathy: A Multidisciplinary Team Approach. , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  G. Lip,et al.  Predictors of 5-year outcomes in malignant phase hypertension: the West Birmingham Malignant Hypertension Registry , 2017, Journal of hypertension.

[9]  D. Kavanagh,et al.  Thrombotic Microangiopathy and the Kidney. , 2017, Clinical journal of the American Society of Nephrology : CJASN.

[10]  Sung-Soo Yoon,et al.  Clinical dissection of thrombotic microangiopathy , 2017, Annals of Hematology.

[11]  C. Reutelingsperger,et al.  Patients with hypertension-associated thrombotic microangiopathy may present with complement abnormalities. , 2017, Kidney international.

[12]  D. Chauveau,et al.  Predictive features of chronic kidney disease in atypical haemolytic uremic syndrome , 2017, PloS one.

[13]  J. Shatzel,et al.  Syndromes of Thrombotic Microangiopathy. , 2017, The Medical clinics of North America.

[14]  J. Köhl,et al.  A pathogenic role of complement in arterial hypertension and hypertensive end organ damage. , 2017, American journal of physiology. Heart and circulatory physiology.

[15]  D. Chauveau,et al.  Thrombotic thrombocytopenic purpura misdiagnosed as autoimmune cytopenia: Causes of diagnostic errors and consequence on outcome. Experience of the French thrombotic microangiopathies reference centre , 2017, American journal of hematology.

[16]  G. Lip,et al.  From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency , 2016, Journal of Human Hypertension.

[17]  É. Azoulay,et al.  Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy. , 2016, The Lancet. Haematology.

[18]  A. Asif,et al.  The endothelium as the common denominator in malignant hypertension and thrombotic microangiopathy. , 2016, Journal of the American Society of Hypertension : JASH.

[19]  S. Vesely,et al.  Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura. , 2013, Blood.

[20]  Jeroen J. Bax,et al.  2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Blood pressure.

[21]  L. Rostaing,et al.  Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[22]  J. Kellum,et al.  Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1) , 2013, Critical Care.

[23]  R. Benecke,et al.  Insular stroke is associated with acute sympathetic hyperactivation and immunodepression , 2013, European journal of neurology.

[24]  T. Benzing,et al.  Indicators of Acute and Persistent Renal Damage in Adult Thrombotic Microangiopathy , 2012, PloS one.

[25]  S. Muto,et al.  Clinical Features of Malignant Hypertension with Thrombotic Microangiopathy , 2011, Clinical and experimental hypertension.

[26]  J. George.  The thrombotic thrombocytopenic purpura and hemolytic uremic syndromes: overview of pathogenesis (Experience of The Oklahoma TTP-HUS Registry, 1989-2007). , 2009, Kidney international. Supplement.

[27]  Ian Mackie,et al.  Regional UK TTP Registry: correlation with laboratory ADAMTS 13 analysis and clinical features , 2008, British journal of haematology.

[28]  P. Lenting,et al.  Association Between Thrombotic Microangiopathy and Reduced ADAMTS13 Activity in Malignant Hypertension , 2008, Hypertension.

[29]  H. Tsai.  The kidney in thrombotic thrombocytopenic purpura. , 2007, Minerva medica.

[30]  G. V. van Montfrans,et al.  The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension. , 2007, American journal of hypertension.

[31]  S. Park,et al.  Headache as a Predictive Factor of Severe Systolic Hypertension in Acute Ischemic Stroke , 2003, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[32]  G. Hutchins,et al.  Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome are distinct pathologic entities. A review of 56 autopsy cases. , 2003, Archives of pathology & laboratory medicine.

[33]  K. Heathfield,et al.  A Case of Malignant Hypertension with Haemolytic Anaemia , 1964, British medical journal.

[34]  K. Heathfield,et al.  Treatment of Petit Mal with Ethosuximide: Follow-up Report , 1964, British medical journal.

[35]  Helmut Baumgartner,et al.  The 2013 ESH/ESC guidelines for the management of arterial hypertension , 2013 .

[36]  M. Matsumoto,et al.  Registry of 919 patients with thrombotic microangiopathies across Japan: database of Nara Medical University during 1998-2008. , 2010, Internal medicine.

[37]  H. Tiddens,et al.  Haemolytic uraemic syndrome. , 1979, Paediatrician.